RYDAPT© APPROVED FOR ADVANCED SYSTEMIC MASTOCYTOSIS VARIANTS!RYDAPT© APPROVED FOR ADVANCED SYSTEMIC MASTOCYTOSIS VARIANTS! The Mastocytosis Society, Inc. is very excited to … RYDAPT© APPROVED FOR ADVANCED SYSTEMIC MASTOCYTOSIS VARIANTS! Learn More
Deciphera Pharmaceuticals Presents: Living with Systemic Mastocytosis (SM) WebExOliver Rosen, MD, former Chief Medical Officer at Deciphera Pharmaceuticals, and Kathy Gram, RN, Head … Deciphera Pharmaceuticals Presents: Living with Systemic Mastocytosis (SM) WebEx Learn More
Informational Webcast on Avapritinib Clinical Trial Program in Systemic Mastocytosis (SM)On Tuesday, September 18, The Mastocytosis Society and Blueprint Medicines hosted a webinar for the SM … Informational Webcast on Avapritinib Clinical Trial Program in Systemic Mastocytosis (SM) Learn More
Sharing a Patient Perspective at Deciphera PharmaceuticalsJanice Chiappione, a local patient living with systemic mastocytosis, visited the company and spoke to … Sharing a Patient Perspective at Deciphera Pharmaceuticals Learn More
Informational Webinar on Avapritinib Clinical Trial Program for Systemic MastocytosisDuring the webcast, Dr. Andy Boral, Chief Medical Officer of Blueprint Medicines, shared an update … Informational Webinar on Avapritinib Clinical Trial Program for Systemic Mastocytosis Learn More
AWaRDS STUDY: ADULTS WITH RARE DISORDERS SUPPORTAWaRDS STUDY: ADULTS WITH RARE DISORDERS SUPPORT Apr 03, 2017 Preliminary AWaRDS Results: Bogart KR, … AWaRDS STUDY: ADULTS WITH RARE DISORDERS SUPPORT Learn More
